Exit this survey

31st Annual TNP Conference Session F17 Evaluation - The Buprenorphine Team: MAT for Patients hospita

Speaker: Richard Bottner
Friday, September 6, 2019

Question Title

* 1. F17: As a result of my participation inThe Buprenorphine Team: MAT for Patients hospitalized on Medical and Surgical Wards, I am better to:

  Strongly Disagree Disagree Agree Strongly Agree
Summarize the most recent national epidemiology of opioid use disorder.
Describe the benefits of buprenorphine induction for admitted patients with opioid use disorder
Apply concepts of hospital-based buprenorphine induction to their own institution.

Question Title

* 2. The teaching methods used were appropriate to the objectives.

Question Title

* 3. The presenter demonstrated experiential knowledge of the topic.

Question Title

* 4. The individual objectives/content topic were cohesive with one another.

Question Title

* 5. The content of the program was fair and balanced.

Question Title

* 6. The content of the program was free of commercial bias.

Question Title

* 7. Speaker fully disclosed any conflict of interest and discussion of off-label usage of medication and/or medical devices at beginning of, or during the presentation.

Question Title

* 8. I would recommend this speaker for future conference.

T